Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Common Equity (2016 - 2025)

Cavitation Technologies' Common Equity history spans 14 years, with the latest figure at -$248000.0 for Q4 2025.

  • For Q4 2025, Common Equity fell 978.26% year-over-year to -$248000.0; the TTM value through Dec 2025 reached -$248000.0, down 978.26%, while the annual FY2025 figure was $69000.0, 114.37% up from the prior year.
  • Common Equity for Q4 2025 was -$248000.0 at Cavitation Technologies, down from -$189000.0 in the prior quarter.
  • Across five years, Common Equity topped out at $1.0 million in Q2 2022 and bottomed at -$1.2 million in Q4 2023.
  • The 5-year median for Common Equity is -$106000.0 (2024), against an average of -$81650.0.
  • The largest annual shift saw Common Equity soared 352.07% in 2022 before it tumbled 978.26% in 2025.
  • A 5-year view of Common Equity shows it stood at $378000.0 in 2021, then skyrocketed by 75.66% to $664000.0 in 2022, then crashed by 278.61% to -$1.2 million in 2023, then surged by 98.06% to -$23000.0 in 2024, then crashed by 978.26% to -$248000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVAT's Common Equity are -$248000.0 (Q4 2025), -$189000.0 (Q3 2025), and $69000.0 (Q2 2025).